SARS-associated coronavirus transmission, United States

被引:37
|
作者
Isakbaeva, ET
Khetsuriani, N
Beard, RS
Peck, A
Erdman, D
Monroe, SS
Tong, SX
Ksiazek, TG
Lowther, S
Pandya-Smith, I
Anderson, LJ
Lingappa, J
Widdowson, MA
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
[2] McKing Consulting, Atlanta, GA USA
关键词
D O I
10.3201/eid1002.030734
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To better assess the risk for transmission of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV), we obtained serial specimens and clinical and exposure data from seven confirmed U.S. SARS patients and their 10 household contacts. SARS-CoV was detected in a day-14 sputum specimen from one case-patient and in five stool specimens from two case-patients. In one case-patient, SARS-CoV persisted in stool for at least 26 days after symptom onset. The highest amounts of virus were in the day-14 sputum sample and a day-14 stool sample. Residual respiratory symptoms were still present in recovered SARS case-patients 2 months after illness onset. Possible transmission of SARS-CoV occurred in one household contact, but this person had also traveled to a SARS-affected area. The data suggest that SARS-CoV is not always transmitted efficiently. Routine collection and testing of stool and sputum specimens of probable SARS case-patients may help the early detection of SARS-CoV infection.
引用
收藏
页码:225 / 231
页数:7
相关论文
共 50 条
  • [1] SARS-associated coronavirus
    Holmes, KV
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20): : 1948 - 1951
  • [2] Animal-to-human SARS-associated coronavirus transmission?
    Lun, ZR
    Qu, LH
    EMERGING INFECTIOUS DISEASES, 2004, 10 (05) : 959 - 959
  • [3] Fusogenic mechanism of SARS-associated coronavirus
    Liu, S
    He, Y
    Debnath, AK
    Jiang, S
    ANTIVIRAL RESEARCH, 2004, 62 (02) : A60 - A60
  • [4] The genome sequence of the SARS-associated coronavirus
    Marra, MA
    Jones, SJM
    Astell, CR
    Holt, RA
    Brooks-Wilson, A
    Butterfield, YSN
    Khattra, J
    Asano, JK
    Barber, SA
    Chan, SY
    Cloutier, A
    Coughlin, SM
    Freeman, D
    Girn, N
    Griffith, OL
    Leach, SR
    Mayo, M
    McDonald, H
    Montgomery, SB
    Pandoh, PK
    Petrescu, AS
    Robertson, AG
    Schein, JE
    Siddiqui, A
    Smailus, DE
    Stott, JE
    Yang, GS
    Plummer, F
    Andonov, A
    Artsob, H
    Bastien, N
    Bernard, K
    Booth, TF
    Bowness, D
    Czub, M
    Drebot, M
    Fernando, L
    Flick, R
    Garbutt, M
    Gray, M
    Grolla, A
    Jones, S
    Feldmann, H
    Meyers, A
    Kabani, A
    Li, Y
    Normand, S
    Stroher, U
    Tipples, GA
    Tyler, S
    SCIENCE, 2003, 300 (5624) : 1399 - 1404
  • [5] SARS-associated coronavirus infection in teenagers
    Yang, GG
    Lin, SZ
    Liao, KW
    Lee, JJ
    Wang, LS
    EMERGING INFECTIOUS DISEASES, 2004, 10 (02) : 382 - 383
  • [6] SARS-associated coronavirus quasispecies in individual patients
    Xu, DP
    Zhang, Z
    Wang, FS
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (13): : 1366 - 1367
  • [7] Effects of a SARS-associated coronavirus vaccine in monkeys
    Gao, WT
    Tamin, A
    Soloff, A
    D'Aiuto, L
    Nwanegbo, E
    Robbins, PD
    Bellini, WJ
    Barratt-Boyes, S
    Gambotto, A
    LANCET, 2003, 362 (9399): : 1895 - 1896
  • [8] SARS-associated coronavirus replication in cell lines
    Kaye, M
    Druce, J
    Tran, T
    Kostecki, R
    Chibo, D
    Morris, J
    Catton, M
    Birch, C
    EMERGING INFECTIOUS DISEASES, 2006, 12 (01) : 128 - 133
  • [9] Piezoelectric immunosensor for SARS-associated coronavirus in sputum
    Zuo, BL
    Li, SM
    Guo, Z
    Zhang, JF
    Chen, CZ
    ANALYTICAL CHEMISTRY, 2004, 76 (13) : 3536 - 3540
  • [10] Proteolysis of SARS-associated coronavirus spike glycoprotein
    Simmons, Graham
    Rennekamp, Andrew J.
    Bates, Paul
    NIDOVIRUSES: TOWARD CONTROL OF SARS AND OTHER NIDOVIRUS DISEASES, 2006, 581 : 235 - 240